120 related articles for article (PubMed ID: 2241187)
21. Effects of sodium thiosulfate in combination therapy of cis-dichlorodiammineplatinum and vindesine.
Hirosawa A; Niitani H; Hayashibara K; Tsuboi E
Cancer Chemother Pharmacol; 1989; 23(4):255-8. PubMed ID: 2538252
[TBL] [Abstract][Full Text] [Related]
22. [Change of creatinine clearance rate in accordance with aging in Japanese patients with head and neck cancer].
Nishimura G; Horiuchi C; Yoshida T; Kawakami M; Yabuki K; Taguchi T; Nagao J; Kondo N; Masuda Y; Matsuda H; Mikami Y; Tsukuda M
Gan To Kagaku Ryoho; 2006 Apr; 33(4):463-6. PubMed ID: 16612154
[TBL] [Abstract][Full Text] [Related]
23. [Chemotherapy of metastatic urothelial carcinoma. cis-Diamminedichloroplatinum combination chemotherapy for patients with decreased renal function].
Kihara K; Kusuyama H; Washizuka M; Kawai T
Hinyokika Kiyo; 1984 Jan; 30(1):21-8. PubMed ID: 6539559
[TBL] [Abstract][Full Text] [Related]
24. Comparative study of the acute nephrotoxicity from standard dose cisplatin +/- ifosfamide and high-dose chemotherapy with carboplatin and ifosfamide.
Hartmann JT; Fels LM; Franzke A; Knop S; Renn M; Maess B; Panagiotou P; Lampe H; Kanz L; Stolte H; Bokemeyer C
Anticancer Res; 2000; 20(5C):3767-73. PubMed ID: 11268452
[TBL] [Abstract][Full Text] [Related]
25. [Studies on renal dysfunction after intra-arterial hypertensive chemotherapy (CDDP, PEP) for advanced cancer of the uterine cervix--serum.urinary alpha 1-microglobulin, beta 2-microglobulin and urinary lysozyme, albumin].
Iwanari O; Date Y; Yoshino N; Miyako J; Ryuhkoh K; Moriyama M; Nakayama S; Kitao M
Nihon Sanka Fujinka Gakkai Zasshi; 1990 Feb; 42(2):115-20. PubMed ID: 1690251
[TBL] [Abstract][Full Text] [Related]
26. [The prevention of CDDP-induced emesis with a combination regimen including metoclopramide, dexamethasone, droperidol and diphenhydramine].
Dozono H; Yasuda M; Yokoyama S; Takahashi S; Ochiai K; Tsuruoka M; Morimoto O; Sasaki H; Arihiro T; Terashima Y
Nihon Sanka Fujinka Gakkai Zasshi; 1987 Nov; 39(11):1968-72. PubMed ID: 3429979
[TBL] [Abstract][Full Text] [Related]
27. Telmisartan Exacerbates Cisplatin-Induced Nephrotoxicity in a Mouse Model.
Hosoda A; Matsumoto Y; Toriyama Y; Tsuji T; Yoshida Y; Masamichi S; Kohno T
Biol Pharm Bull; 2020; 43(9):1331-1337. PubMed ID: 32879207
[TBL] [Abstract][Full Text] [Related]
28. [A study of CDDP in the treatment of patients with gastric and esophageal cancers, with special reference to the evaluation of renal functions before and after CDDP administration].
Sasaki E; Namatame K; Hirose C; Hamai N; Onomura Y; Miyata N; Kusumoto S; Makuuchi M; Iwai H; Asakawa K
Gan To Kagaku Ryoho; 1988 Sep; 15(9):2713-7. PubMed ID: 3415269
[TBL] [Abstract][Full Text] [Related]
29. [High-dose CDDP therapy using a balloon-occluded arterial infusion (BOAI) in recurrent ovarian cancer].
Suzumori K; Yasui Y; Yagami Y; Mimura M; Banno T; Nakamura T
Gan No Rinsho; 1988 Aug; 34(9):1107-14. PubMed ID: 3172517
[TBL] [Abstract][Full Text] [Related]
30. [Clinical investigation of cis-platinum nephrotoxicity in 244 cases of primary lung cancer].
Soejima A; Inoue T; Suzuki M; Waku M; Nakabayashi K; Kitamoto K; Nagasawa T
Nihon Jinzo Gakkai Shi; 1992 Jul; 34(7):801-6. PubMed ID: 1479719
[TBL] [Abstract][Full Text] [Related]
31. [Acute nephrotoxicity by CDDP (on tubular damage)].
Higuchi K; Negoro Y; Suzuki M; Noguchi M; Nakanishi M; Ishihara M; Nakano M
Gan To Kagaku Ryoho; 1991 Jan; 18(1):85-9. PubMed ID: 1987905
[TBL] [Abstract][Full Text] [Related]
32. [Studies on serum and urinary alpha 1-microglobulin levels as parameter of the renal function--renal function observed after CDDP administration].
Ujiie T; Maruta H; Ito N
Hinyokika Kiyo; 1988 May; 34(5):790-6. PubMed ID: 2459938
[TBL] [Abstract][Full Text] [Related]
33. [Hypomagnesemia following chemotherapy of disseminated testicular tumors].
Hida S; Nishimura K; Nishio Y; Okada Y; Okada K; Yoshida O
Hinyokika Kiyo; 1988 Jan; 34(1):52-60. PubMed ID: 2454015
[TBL] [Abstract][Full Text] [Related]
34. A phase II study of combination chemotherapy in advanced ovarian carcinoma with cisplatin and cyclophosphamide plus reduced glutathione as potential protective agent against cisplatin toxicity.
Locatelli MC; D'Antona A; Labianca R; Vinci M; Tedeschi M; Carcione R; Corbo A; Venturino P; Luporini G
Tumori; 1993 Feb; 79(1):37-9. PubMed ID: 8497920
[TBL] [Abstract][Full Text] [Related]
35. [Effects of fractionated low dose Cisplatin on renal functions of patients with gastric carcinoma].
Li Y; Shen L; Li J; Jin ML
Ai Zheng; 2007 Dec; 26(12):1354-6. PubMed ID: 18076800
[TBL] [Abstract][Full Text] [Related]
36. [Prevention of cisplatin induced nephrotoxicity by administering urinastatin to rabbits--comparison with other protease inhibitors].
Kobayashi H; Ohi H; Kawashima Y
Nihon Sanka Fujinka Gakkai Zasshi; 1989 Jun; 41(6):683-7. PubMed ID: 2475558
[TBL] [Abstract][Full Text] [Related]
37. Urinary excretion of beta 2-microglobulin and N-acetyl-beta-D-glucosaminidase in advanced neuroblastoma patients receiving cis-diamminedichloroplatinum(II).
Ikeda H; Nagashima K; Okumura H; Takahashi A; Matsuyama S; Nagamachi Y
Eur J Surg Oncol; 1988 Feb; 14(1):17-20. PubMed ID: 3278937
[TBL] [Abstract][Full Text] [Related]
38. [Effects and side effects of hypertensive intra-arterial chemotherapy (CDDP, PEP) in advanced cancer of the uterine cervix].
Iwanari O; Date Y; Yoshino N; Miyako J; Ryukou K; Moriyama M; Nakayama S; Kitao M; Fujita Y; Yasui K
Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):2792-6. PubMed ID: 2476964
[TBL] [Abstract][Full Text] [Related]
39. [Effects of Renal Function Evaluation with or without Serum Creatinine Adjustment on Cisplatin/Fluorouracil Therapy for Cervical Cancer].
Takagi M; Sagara A; Ishizawa A; Ito A; Miyazaki M; Senzaki K; Nagai T; Yamada K
Yakugaku Zasshi; 2019; 139(10):1327-1332. PubMed ID: 31582618
[TBL] [Abstract][Full Text] [Related]
40. A phase I study of continuous administration of 5-fluorouracil/cisplatin in advanced uterine cervical cancer.
Yoshida Y; Goto K; Kawahara K; Kurokawa T; Shukunami K; Kotsuji F
Anticancer Res; 2002; 22(6B):3473-6. PubMed ID: 12552941
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
